VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Nuvation Bio Inc. (NUVB) Total Return Calculator with Dividends Reinvested

Nuvation Bio Inc.

Popular:

The total return for Nuvation Bio Inc. (NUVB) stock is +141.15% over the past 12 months. So far it's down 41.26% this year. The 5-year total return is -54.26%, meaning $10,000 invested in NUVB stock 5 years ago would be worth $4,574 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in NUVB 1 year ago, it would be worth $24,706 today — you'd have gained $14,706.

With Dividends Reinvested$24,706+147.06%

Price Only (No DRIP)$24,706+147.06%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in NUVB

1Y$24,115+$14,115 (+141.1%)141.1% CAGR

3Y$31,111+$21,111 (+211.1%)46.0% CAGR

5Y$4,574-$5,426 (-54.3%)-14.5% CAGR

10Y$5,040-$4,960 (-49.6%)-6.6% CAGR

15Y$5,040-$4,960 (-49.6%)-4.5% CAGR

20Y$5,040-$4,960 (-49.6%)-3.4% CAGR

30Y$5,040-$4,960 (-49.6%)-2.3% CAGR

Nuvation Bio Inc. did not pay dividends during this period. Total return = price return.

Loading NUVB total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-41.26%	—	-41.26%	—	$5,874
1Y	+141.15%	141.15%	+141.15%	—	$24,115
3Y	+211.11%	45.98%	+211.11%	—	$31,111
5Y	-54.26%	-14.48%	-54.26%	—	$4,574
10Y	-49.60%	-6.62%	-49.60%	—	$5,040
15Y	-49.60%	-4.47%	-49.60%	—	$5,040
20Y	-49.60%	-3.37%	-49.60%	—	$5,040
30Y	-49.60%	-2.26%	-49.60%	—	$5,040

Risk & Highlights

Best Year+245.95%2025

Worst Year-78.26%2022

Max Drawdown-57.55%2025-12-22 → 2026-03-30

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-31.12%	-31.12%	—	+0.41%	-31.5pp
2025	+245.95%	+245.95%	—	+16.64%	+229.3pp
2024	+69.43%	+69.43%	—	+24.00%	+45.4pp
2023	-25.25%	-25.25%	—	+24.81%	-50.1pp
2022	-78.26%	-78.26%	—	-19.95%	-58.3pp

NUVB outperformed the S&P 500 by 109.83pp over the past year (+141.15% vs +31.32%).

Loading summary...

NUVB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
NUVBNuvation Bio Inc.	$1.7B	+13.3%	-41.3%	+141.1%	—	+211.1%	-54.3%	-49.6%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
TPSTTempest Therapeutics, Inc.	$56M	+27.0%	-31.5%	-69.7%	—	-92.4%	-87.9%	-99.9%
PRAXPraxis Precision Medicines, Inc.	$7.6B	+9.0%	+18.0%	+860.9%	—	+2005.6%	-18.4%	-19.0%
RVMDRevolution Medicines, Inc.	$32.1B	+58.2%	+91.2%	+303.5%	—	+518.1%	+420.9%	+422.7%
AUPHAurinia Pharmaceuticals Inc.	$2.1B	+1.5%	+5.8%	+100.1%	—	+45.2%	+31.6%	+552.4%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
ARVNArvinas, Inc.	$656M	-8.6%	-10.5%	+47.6%	—	-58.4%	-83.8%	-36.1%
KRYSKrystal Biotech, Inc.	$8.5B	+10.3%	+17.0%	+107.1%	—	+229.6%	+310.3%	+2615.2%
PTGXProtagonist Therapeutics, Inc.	$6.6B	+1.0%	+19.3%	+147.5%	—	+317.0%	+271.1%	+788.6%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.3%	+1.5%	+134.1%	—	+19.0%	+50.9%	+125.0%

Compare:NUVB vs KYMR NUVB vs TPST NUVB vs PRAX NUVB vs KYMR vs TPST

About NUVB Dividend Returns

Nuvation Bio Inc. (NUVB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of NUVB over the past year?

Nuvation Bio Inc. (NUVB) delivered a return of 141.15% over the past year. Since NUVB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in NUVB be worth today?

A $10,000 investment in Nuvation Bio Inc. one year ago would be worth $24,115 today, representing a gain of $14,115.

Q3Does NUVB pay dividends?

Nuvation Bio Inc. (NUVB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For NUVB, the total return equals the price-only return.

Q4Did NUVB beat the S&P 500?

Yes, Nuvation Bio Inc. (NUVB) outperformed the S&P 500 by 109.83 percentage points over the past year. NUVB delivered a total return of 141.15%, compared to the S&P 500's 31.32%. This 109.83pp alpha means investors in NUVB earned more than a passive S&P 500 index fund.

Q5What is NUVB's worst drawdown?

Nuvation Bio Inc. (NUVB) experienced a maximum drawdown of -57.55% over the past year, declining from its peak on 2025-12-22 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is NUVB's long-term total return over 10, 20, or 30 years?

Here are Nuvation Bio Inc. (NUVB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -49.6% (-6.6% CAGR) — $10,000 would have grown to $5,040. Over 20 years: -49.6% total return (-3.4% CAGR) — $10,000 → $5,040. Over 30 years: -49.6% total return (-2.3% CAGR) — $10,000 → $5,040. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was NUVB's best and worst year?

Nuvation Bio Inc.'s best calendar year was 2025 with a total return of 245.9%. Its worst year was 2022 with a total return of -78.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 324.2 percentage points.